Keywords: USA, Rheumatologists, Rheumatoid arthritis treatments, Biologics, Decision Resources, Rituxan, Orencia, Actemra, Enbrel, Humira

US rheumatologists continue to increase use of biologics for RA treatment

Article | 29 March 2012

Print This

Biologic agents remain the preferred treatment for patients suffering from rheumatoid arthritis (RA), according to a new survey of US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in